Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Wark

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Clinical Evidence|January 18, 2005
Bronchitis (acute)Peter Wark
Clinical Evidence|September 16, 2006
Bronchitis (acute)Peter Wark
Respirology Case Reports|May 9, 2018
Pseudomonas pharyngitis in a cystic fibrosis patientShyamala Pradeepan, Peter Wark
Paediatric Respiratory Reviews|November 26, 2008
Innate immune response to viral infection of the lungsHayley See, Peter Wark
Australian Prescriber|May 13, 2024
Biologic therapies for severe asthma with persistent type 2 inflammationSahan Chandrasekara, Peter Wark
The European Respiratory Journal|August 3, 2023
Long-term therapy with elexacaftor/tezacaftor/ivacaftor (ETI) in cystic fibrosis: improved clinical outcomes but infection and inflammation persistMichael M Tunney, Peter Wark
The Cochrane Database of Systematic Reviews|April 17, 2009
Nebulised hypertonic saline for cystic fibrosisPeter Wark, Vanessa M McDonald
The Cochrane Database of Systematic Reviews|September 28, 2018
Nebulised hypertonic saline for cystic fibrosisPeter Wark, Vanessa M McDonald
Respirology (Carlton, Vic.)|June 18, 2024
Allergic broncho-pulmonary aspergillosis: Old disease, new frontiersEve Denton, Peter Wark, Mark Hew
The Cochrane Database of Systematic Reviews|June 15, 2023
Nebulised hypertonic saline for cystic fibrosisPeter Wark, Vanessa M McDonald, Sherie Smith
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Clinical Evidence|January 18, 2005
Bronchitis (acute)Peter Wark
Clinical Evidence|September 16, 2006
Bronchitis (acute)Peter Wark
Respirology Case Reports|May 9, 2018
Pseudomonas pharyngitis in a cystic fibrosis patientShyamala Pradeepan, Peter Wark
Paediatric Respiratory Reviews|November 26, 2008
Innate immune response to viral infection of the lungsHayley See, Peter Wark
Australian Prescriber|May 13, 2024
Biologic therapies for severe asthma with persistent type 2 inflammationSahan Chandrasekara, Peter Wark
The European Respiratory Journal|August 3, 2023
Long-term therapy with elexacaftor/tezacaftor/ivacaftor (ETI) in cystic fibrosis: improved clinical outcomes but infection and inflammation persistMichael M Tunney, Peter Wark
The Cochrane Database of Systematic Reviews|April 17, 2009
Nebulised hypertonic saline for cystic fibrosisPeter Wark, Vanessa M McDonald
The Cochrane Database of Systematic Reviews|September 28, 2018
Nebulised hypertonic saline for cystic fibrosisPeter Wark, Vanessa M McDonald
Respirology (Carlton, Vic.)|June 18, 2024
Allergic broncho-pulmonary aspergillosis: Old disease, new frontiersEve Denton, Peter Wark, Mark Hew
The Cochrane Database of Systematic Reviews|June 15, 2023
Nebulised hypertonic saline for cystic fibrosisPeter Wark, Vanessa M McDonald, Sherie Smith
Pageof 7